Paul B. Eckburg MD
Infectious Diseases at Stanford University and Anti-Infective Drug Development in Industry
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Eckburg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care2004
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2000 - 2002- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1996 - 1999
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1996 - 1997
Rush Medical College of Rush University Medical CenterClass of 1996
Certifications & Licensure
CA State Medical License 1997 - 2027
HI State Medical License 1999 - 1999
Clinical Trials
- Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Start of enrollment: 2007 Mar 01
- Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Start of enrollment: 2007 Feb 01
- Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia Start of enrollment: 2007 Jul 01
Publications & Presentations
PubMed
- 1 citationsEvaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis.Sujata M Bhavnani, Jeffrey P Hammel, Christopher M Rubino, Angela K Talley, Paul B Eckburg
Open Forum Infectious Diseases. 2024-09-01 - 1 citationsEffect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial.Tsegaye Sewunet, Mohammad Razavi, Staffan Rosenborg, Angela Camporeale, Michael Nowak
The Lancet. Microbe. 2024-04-01 - 3 citationsImpact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections.David Melnick, Angela K Talley, Vipul K Gupta, Ian A Critchley, Paul B Eckburg
Antimicrobial Agents and Chemotherapy. 2023-10-18
Press Mentions
Recida Therapeutics Raises $8.5M in Series AFebruary 9th, 2019
Frazier Healthcare Partners Launches Recida Therapeutics to Develop Novel Therapeutics for Serious Antibiotic-Resistant InfectionsFebruary 6th, 2019- UTILITY Receives Qualified Infectious Disease Product Designation from the U.S. FDAMay 21st, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
